SCHEMBL308102

SCHEMBL308102

Cn1cncc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2399343 0.70
SCHEMBL23026437 0.67
SCHEMBL15202154 0.67
SCHEMBL730978 0.67
SCHEMBL557254 0.67
SCHEMBL1234972 0.67
SCHEMBL3836708 0.67
SCHEMBL4499348 0.67
Hydrochloric Acid SCHEMBL23699967 0.65
SCHEMBL31216559 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043635-B2 Products comprising 1,2,3-triazolate metal-organic frameworks and methods of making and using the same UNIVERSITY OF OREGON (US) 2024-07-23 US claimed
CN-117534534-B Preparation method of cyclopentadiene trimer 广东新华粤石化集团股份公司 2024-07-05 CN claimed
CN-117534534-A Preparation method of cyclopentadiene trimer 广东新华粤石化集团股份公司 2024-02-09 CN claimed
US-20230140398-A1 PRODUCTS COMPRISING 1,2,3-TRIAZOLATE METAL-ORGANIC FRAMEWORKS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF OREGON (US) 2023-05-04 US claimed
US-20140031289-A1 POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-01-30 US claimed
US-20090056795-A1 ELECTROLYTE FOR SOLAR CELL AND SOLAR CELL HAVING THE SAME SAMSUNG SDI CO., LTD. (KR) 2009-03-05 US claimed
EP-4695236-A1 SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2026-02-18 EP disclosed
US-12528781-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2026-01-20 US disclosed
US-12485169-B2 Compounds Grey Wolf Therapeutics Limited (GB) 2025-12-02 US disclosed
WO-2025228900-A1 ARYLAMIDE SUBSTITUTED INDAZOLES AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-06 WO disclosed
WO-2025228902-A1 HETEROCYCLIC ACIDS AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-06 WO disclosed
WO-2025228899-A1 FURTHER HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-06 WO disclosed
WO-2025228892-A1 MONOARYL AND HETARYL SUBSTITUTED INDAZOLES AND BENZIMIDAZOLES AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-06 WO disclosed
CN-1118793-A Latent catalysts, cure-inhibited epxoy resin compositions and laminates prepared therefrom DOW CHEMICAL CO (US) 1996-03-20 CN disclosed
CN-1118794-A Latent Catalysts, Cure-inhibited epxoy resin compositions and laminates prepared therefrom DOW CHEMICAL CO (US) 1996-03-20 CN disclosed
WO-1995006645-A1 BENZOFURAN DERIVATIVES AS TACHYKININ ANTAGONISTS GLAXO GROUP LIMITED (GB) 1995-03-09 WO disclosed
CN-1056699-A Latent catalysts and cure-inhibited epoxy resin compositions and laminates made therefrom DOW CHEMICAL CO (US) 1991-12-04 CN disclosed
US-4824955-A ANTITUMOR AGENTS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1989-04-25 US disclosed
CN-86107767-A NOVEL ORGANIC SELENIUM COMPOUNDS 1987-08-05 CN disclosed
EP-0222414-A2 Novel organic selenium compounds NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1987-05-20 EP disclosed